Skip to main content

Table 1 Patient characteristics

From: Nothing to lose: a grounded theory study of patients’ and healthcare professionals’ perspectives of being involved in the consent process for oncology trials with non-curative intent

Participant

Gender

Cancer Diagnosis

Trial Phase

Accept trial?

Time from initial interview to death

P01

F

Breast

I

Yes

10 weeks

P02

M

Oesophagus

III

Yes

16 months

P03

F

Pancreatic

III

No

7 weeks

P04

M

Prostate

III

Yes

Alive

P05

F

Breast

I

Yes

3 months

P06

M

Prostate

III

Yes

29 months

P07

M

Prostate

III

No

3 months

P08

M

Prostate

III

Yes

Alive

P09

M

Colorectal

II

Yes

16 months

P10

M

Pancreatic

III

Yes

17 months

P11

M

Pancreatic

III

Yes

11 months

P12

F

Myeloma

III

Yes

Alive

P13

M

Pancreatic

III

No

6 months

P14

M

Colorectal

II

Yes

5 months

P15

F

Breast

I

Yes

9 months

P16

M

Liver

III

Yes

14 months

  1. Table legend: P = patient